1 / 17

BCR Diagnostics

BCR Diagnostics. Bacteriological Biosensor for Rapid Screening of Platelets Shortly Before Transfusion. Bacterial Chain Reaction for Biomolecular Amplification. Boris Rotman, Ph. D. Vice President and CSO . Jamestown, Rhode Island - bcrbiotech.com. Technical Rationale.

Gabriel
Télécharger la présentation

BCR Diagnostics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BCR Diagnostics Bacteriological Biosensor for Rapid Screening of Platelets Shortly Before Transfusion Bacterial Chain Reaction for Biomolecular Amplification Boris Rotman, Ph. D. Vice President and CSO Jamestown, Rhode Island - bcrbiotech.com

  2. Technical Rationale Biosensor integrates three technologies: 1. LEXSASTM (Label-free Exponential Signal-Amplification System) A recently developed system using engineered spores as fluorogenic nanodetectors. 2.Microfluidics: The detection system is a unique device containing an array of 80,000 microscopic, independent biosensors, each of which is about 5-picoliter volume. This small reaction volume enables detection of individual bacterial cells. The device is termed “80K-bioChip.” 3. Computerized Parallel Imaging The 80K-bioChip provides high-throughput data acquisition and processing.

  3. LEXSAS™Characteristics • Ability to detect and count low bacterial levels. • Quantitative results in less than 20 minutes. • Cost-effective testing. • Linear detection response over a wide dynamic range of one to 10,000 bacteria per sample. • Low instrumentation cost. • Applicability to automated high-throughput operations.

  4. Why using Engineered Spores for Cell-based Biosensing? • Spores are metabolically dormant microorganisms resistant to extreme chemical and physical environmental conditions. • Despite their ruggedness, however, spores remain alert to specific environmental signals that trigger the spores to rapidly break dormancy and initiate germination. • The spores in the LEXSAS™are engineered to be fluorogenic, i.e., the spores are not fluorescent per se, but produce fluorescent light in the presence of nearby bacteria.

  5. Principle of the Biosensor Analyte + germinogenic buffer Bacteria Germination Signals Signal Receptor SPORE Spores Engineered as Fluorogenic Nanodetectors Transduced Fluorescent Signals IMAGE ANALYSIS DATA PROCESSING AND DISPLAY

  6. Response of Engineered Spores to Germinants

  7. Bacterium Schematic of 80K-bioChip[Cross Section]

  8. SEM image of 80K-bioChip[Micro-colanders® are 20 µm dia]

  9. SEM image of Micro-colander®with about 200 Spores

  10. 80K-bioChip mounted on filtration cartridge

  11. Micro-colander® Scanner

  12. Biosensor Operation Platelet sample is processed to separate bacteria, and the resulting suspension is mixed with engineered spores Mixture is combined with germinogenic substrate and then filtered through the 80K-bioChip 80K-bioChip is incubated at 37oC Fluorescent images of 80K-bioChip are captured at time intervals Digital images are processed to yield number of bacteria in the sample

  13. Schematic of 80K-bioChip[Top View] Micro-colanders with one bacterium show visible fluorescence

  14. 80K-BioChip showing ten (10) micro-colanders with significant fluorescence above baseline

  15. Photomicrographs of 80K-bioChip Left: Normal light Right: Fluorescence light

  16. BCR Diagnostics, Inc. • Privately held since 1994 • Technology protected by five U. S. and multiple worldwide Patents (additional U.S. and ROW pending) • Awarded Phase I and Phase II Grants from the Rhode Island Center for Cellular Medicine • Awarded Phase I and Phase II SBIR Grants from the National Institutes of Health

  17. Publications • Rotman, B., Cote, M. A., and Ferencko, L. Phenotypic Engineering of Spores. U. S. Patent pending. • Rotman, B. Analytical system based upon spore germination. U. S. Patent No.6,596,496, March 29, 2005.* • Ferencko, L., Cote, M. A., and Rotman, B. Esterase activity as a novel parameter of spore germination. Biochem. Biophys. Res. Comm., 319: 854-858, 2004. • Rotman, B. and Cote, M. A. Application of a real-time biosensor to detect bacteria in platelet concentrates. Biochem. Biophys. Res. Comm., 300, 197-200, 2003. • Rotman, B. Using living spores for real-time biosensing. Gen. Eng. News, 21, 65, 2001. *Additional patents listed at www.bcrbiotech.com

More Related